Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update

Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 06, 2025 – CHS-114, a highly selective Treg depleter, clinical program expanded to include colorectal cancer – – Q3 2025 ending cash, cash equivalents and marketable securities of $191.7 million – – LOQTORZI(R) net revenue was $11.2 million, a 12% increase […]

SEIU HEALTHCARE ACHIEVES LANDMARK ARBITRATION WIN FOR ONTARIO LONG-TERM CARE

Union-powered WorkersFirst platform ready for adoption by residences as part of transformative approach to healthcare workforce challenges SEIU Healthcare's commitment to building better healthcare solutions for Ontario has achieved a landmark arbitration victory, with Ontario long-term care operators now mandated to sign service agreements for the WorkersFirst digital platform, powered by SEIU Healthcare, to address

Kingsway Reports Third Quarter 2025 Financial Results

— Revenue Growth of 37% to $37.2 Million — — KSX Revenue Growth of 104% to $19.0 Million — — Extended Warranty Revenue Growth of 2% to $18.2 Million; Extended Warranty Cash Sales up 14% — — KSX Represents a Majority of Revenue for First Time — Management to Host Conference Call Today, November 6,

Oxbridge Highlights 2025/26 Contract Performance Updates and Reports Q3 2025 Results

(NASDAQ:OXBR),(NASDAQ:OXBRW), GRAND CAYMAN, Cayman Islands, Nov. 06, 2025 (GLOBE NEWSWIRE) — Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, today reported its results for the three and nine months ended September 30, 2025. SurancePlus 2025-2026 Tokenized Reinsurance Update SurancePlus

Oxbridge Highlights 2025/26 Contract Performance Updates and Reports Q3 2025 Results

Oxbridge Highlights 2025/26 Contract Performance Updates and Reports Q3 2025 Results GlobeNewswire November 06, 2025 GRAND CAYMAN, Cayman Islands, Nov. 06, 2025 (GLOBE NEWSWIRE) — Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, today reported its results for the

Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden

Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON),one of the nation's fastest-growing community oncology networks, today announced a new model enabling high-quality, more affordable, and connected cancer care – all without relying on prior authorization. The national partnership seeks to

Saul Centers, Inc. Reports Third Quarter 2025 Earnings

Saul Centers, Inc. (NYSE: BFS) (the “Company”), an equity real estate investment trust (“REIT”), announced operating results for the quarter ended September 30, 2025 (“2025 Quarter”). Total revenue for the 2025 Quarter increased to $72.0 million from $67.3 million for the quarter ended September 30, 2024 (“2024 Quarter”). Net income decreased to $14.0 million for

PDF Solutions(R) Reports Third Quarter 2025 Financial Results, Announcing Record Third Quarter 2025 Total Revenues

(NASDAQ:PDFS), SANTA CLARA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor and electronics ecosystem, today announced financial results for its third quarter ended September 30, 2025. Financial Highlights of Third Quarter 2025 â— Record quarterly total revenues of $57.1 million, up

Omada Health Announces GLP-1 Prescribing Capability to Support Growing Member Population

(NASDAQ:OMDA), SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced the planned launch of its prescribing capability. After reporting 53% year-over-year member growth as of the end of Q3, the company is also expanding its offerings. A new option of prescribing and medication management

Omada Health Reports Third Quarter 2025 Results

(NASDAQ:OMDA), Revenue of $68 million, up 49%; 53% Member GrowthSignificant Reduction in Net Loss and First Quarter of Positive Adjusted EBITDAAnnounces New GLP-1 Prescribing Offering SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the third quarter ended September 30, 2025.

Scroll to Top